Otsuka Holdings Co Ltd
TSE:4578

Watchlist Manager
Otsuka Holdings Co Ltd Logo
Otsuka Holdings Co Ltd
TSE:4578
Watchlist
Price: 8 594 JPY -0.07% Market Closed
Market Cap: 4.6T JPY
Have any thoughts about
Otsuka Holdings Co Ltd?
Write Note

Otsuka Holdings Co Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Otsuka Holdings Co Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Otsuka Holdings Co Ltd
TSE:4578
Other Liabilities
ÂĄ125.6B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
8%
Takeda Pharmaceutical Co Ltd
TSE:4502
Other Liabilities
ÂĄ790.5B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
17%
Daiichi Sankyo Co Ltd
TSE:4568
Other Liabilities
ÂĄ917.9B
CAGR 3-Years
45%
CAGR 5-Years
31%
CAGR 10-Years
28%
S
Shionogi & Co Ltd
TSE:4507
Other Liabilities
ÂĄ20.5B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Other Liabilities
ÂĄ13.4B
CAGR 3-Years
10%
CAGR 5-Years
-12%
CAGR 10-Years
-2%
Astellas Pharma Inc
TSE:4503
Other Liabilities
ÂĄ195.2B
CAGR 3-Years
38%
CAGR 5-Years
21%
CAGR 10-Years
16%
No Stocks Found

Otsuka Holdings Co Ltd
Glance View

Market Cap
4.6T JPY
Industry
Pharmaceuticals

Otsuka Holdings Co. Ltd. began its journey in 1921 as a small chemicals company in Naruto, Japan. Its evolution from those humble beginnings to a global pharmaceutical giant is marked by its relentless commitment to innovation and expansion. Today, Otsuka operates as a holding company, orchestrating a diversified portfolio across pharmaceuticals, nutraceuticals, consumer products, and medical devices. It has cultivated a unique philosophy: a balance between large-scale operations and niche markets. The company’s pharmaceutical sector, its most significant revenue contributor, is driven largely by advancements in CNS (central nervous system) treatments and nephrology. The success of its flagship product, Abilify, a leading antipsychotic, underscores Otsuka’s ability to combine market demands with cutting-edge research to sustain growth and profitability. In parallel, Otsuka nurtures its nutraceuticals wing, embodied by its signature Pocari Sweat and SoyJoy brands. These products epitomize the company’s strategy of creating and expanding niche markets, offering health-oriented products that resonate with evolving consumer health trends. This diversification into consumer products and nutraceuticals not only complements its pharmaceutical endeavors but also mitigates risks by tapping into varied revenue streams. By focusing on health and wellness broadly, Otsuka Holdings strategically positions itself to navigate the complexities of the global healthcare market, ensuring a resilient business model. Through this multifaceted approach, Otsuka sustains its growth, reaffirming its legacy as a dynamic and globally influential company.

Intrinsic Value
9 450.44 JPY
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Otsuka Holdings Co Ltd's Other Liabilities?
Other Liabilities
125.6B JPY

Based on the financial report for Sep 30, 2024, Otsuka Holdings Co Ltd's Other Liabilities amounts to 125.6B JPY.

What is Otsuka Holdings Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
8%

Over the last year, the Other Liabilities growth was 18%. The average annual Other Liabilities growth rates for Otsuka Holdings Co Ltd have been 3% over the past three years , -1% over the past five years , and 8% over the past ten years .

Back to Top